The global computer vision in healthcare market is projected to expand at a compound annual growth rate (CAGR) of approximately 25% over the forecast period. This robust growth is driven by the ...

Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. The pharmaceutical industry is at a significant crossroads, ...

Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...

AI has infiltrated seemingly every facet of business over the last year. The pharmaceutical industry is no different, and this technology’s rapid evolution can change drug development forever. However ...

Discover the latest pharma quality and manufacturing trends. Digital transformation in pharma is a key move to remain viable in a marketplace that is demanding more personalisation, more quickly than ...

"The pharmaceutical industry is embracing generative AI for several key reasons. First, the industry deals with enormous volumes of information - scientific papers, clinical trial data, regulatory ...

The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...

The pharma industry is projected to see continued growth through 2030 — but not without sizable challenges along the way. By the end of the decade, global prescription drug sales are expected to top ...